Abstract
Medical nutrition therapy (MNT) plays an integral role in the health of the patient with Stage 5 chronic kidney disease (CKD) receiving maintenance dialysis. The health professional must understand the role of nutrition in Stage 5 CKD, the factors affecting assessment and maintenance of adequate nutritional status, and the nutritional implications associated with the different types of renal replacement therapies (RRT). Currently there are almost 400,000 patients receiving RRT in the United States with those numbers expected to steadily increase [1, 2]. The average age of the patient starting dialysis is increasing with a significant number of patients presenting to dialysis with numerous comorbid conditions that may have already negatively impacted their nutritional status. The nutritional status of the patient at the initiation of RRT is an important risk factor for future outcomes, and malnutrition is associated with increased mortality in patients receiving maintenance dialysis [3]. Nutritional management should include ongoing diet education, nutrition assessment, individualized interventions, and monitoring of nutritional status. The goals of MNT in Stage 5 CKD are (a) to achieve and maintain neutral or positive nitrogen balance, (b) to achieve and maintain good nutritional status, (c) to prevent the accumulation of electrolytes and minimize fluid imbalance, and (d) to minimize the effect of metabolic disorders associated with Stage 5 CKD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
US Renal Data System: USRDS 2012 annual data report. www.usrds.org. Accessed 6 Oct 2012.
Gilbertson DT, Liu J, Xue JF, Louis TA, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;10:3736–41.
Pupim LB, Evanson JA, Hakim RM, Ikizler TA. The extent of uremic malnutrition at the time of initiation of maintenance dialysis is associated with the subsequent hospitalization. J Ren Nutr. 2003;13:259–66.
Hakim RM, Levin N. Malnutrition in hemodialysis patients. Am J Kidney Dis. 1993;21:125–37.
Zeir M. Risk of mortality in patients with end-state renal disease: the role of malnutrition and possible therapeutic implications. Horm Res. 2002;56:30–4.
Pupim LB, Caglar K, Hakim RM, Shyr Y, et al. Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int. 2004;66:2054–60.
Kopple JD. Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis. 1994;24:1002–9.
Boxall MC, Goodship THJ. Nutritional requirements in hemodialysis. In: Mitch WE, Klahr S, editors. Handbook of nutrition and the kidney. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 218–27.
Dombros NV, Digenis GE, Oreopoulos DG. Nutritional markers as predictors of survival in patients on CAPD. Perit Dial Int. 1995;15:S10–9.
National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35:S17–103.
Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15:953–60.
Fouqe D, Kalantar-Zadeh K, Kopple J, Cano N, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–8.
Mak RH, Ikizler TA, Kovesdy CP, et al. Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2011;2:9–25.
Kalantar-Zadeh K, Block G, McAllister J, Humphreys MH, et al. Appetite and inflammation, nutrition, anemia and clinical outcomes in hemodialysis patients. Am J Clin Nutr. 2004;80:299–307.
Bossola M, Muscaritoli M, Tazza L, Panocchia N, et al. Variables associated with reduced dietary intake in hemodialysis patients. J Ren Nutr. 2005;15:244–52.
Mehrotra R, Kopple JD. Nutritional management of maintenance dialysis patients: why aren’t we doing better? Ann Rev Nutrition. 2001;21:343–79.
Bergstrom J. Appetite in CAPD patients. Perit Dial Int. 1995;16:8–21.
Kopple JD, Kalantar-Zadeh K, Mehrotra R. Risks of chronic metabolic acidosis in patients with chronic kidney disease. Kidney Int. 2005;67:S21–7.
Papadoyannakis NJ, Stefanidis CJ, McGeown M. The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. Am J Clin Nutr. 1984;40:623–7.
Walls J. Effect of correction of acidosis on nutritional status in dialysis patients. Miner Electrolyte Metab. 1997;23:234–6.
Kalantar-Zadeh K, Mehrotra R, Fouque T, Kopple JD. Metabolic acidosis and malnutrition inflammation complex syndrome in chronic renal failure. Semin Dial. 2004;17:455–65.
Kopple JD, Kalantar-Zadeh K. Malnutrition and IDPN in patients with ESRD. In: Principles and practices of dialysis. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 473–88.
Kalantar-Zadeh K, Kopple JD. Nutritional management of patients undergoing maintenance hemodialysis. In: Kopple JD, Massry SG, editors. Kopple and Massry’s nutritional management of renal disease. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 433–58.
Bossola M, Muscaritoli M, Tazza L, Giungi S, et al. Malnutrition in hemodialysis patients: what therapy? Am J Kidney Dis. 2005;46:371–86.
Ikizler TA. Nutrition and peritoneal dialysis. In: Handbook of nutrition and the kidney. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 228–44.
Gutierrez A, Bergstrom J, Alvestrand A. Protein catabolism in sham-hemodialysis: the effect of different membranes. Clin Nephrol. 1992;38:20–9.
Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int. 1994;46:830–7.
Fouque D, Pelletier S, Guebre-Egziabher F. Have recommended protein and phosphate intake recently changed in maintenance hemodialysis? J Ren Nutr. 2011;1:35–8.
Kaplan AA, Halley SE, Lapkin RA, Graeber CW. Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int. 1995;47:573–8.
Ikizler TA, Pupim LA, Brouillette JR, Levenhagen DK, et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab. 2002;282:E107–16.
Pupim LB, Flakoll PJ, Ikizler TA. Protein homeostasis in chronic hemodialysis patients. Curr Opin Clin Nutr Metab Care. 2004;7:890–5.
Bergstrom J. Why are dialysis patients malnourished? Am J Kidney Dis. 1995;26:229–41.
Jager KJ, Merkus MP, Husiman RM, Boeschoten EW, et al. Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 2001;12:1272–9.
Rocco MV, Dwyer JT, Larive B, Greene T, et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO study. Kidney Int. 2004;65:2321–34.
McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, et al. How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int Suppl. 1996;56:S56–61.
National Kidney Foundation. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis. 2006;48:S98–129.
Punal J, Lema LV, Sanhez-Guisande D, Ruano-Ravina A. Clinical effectiveness and quality of life of conventional haemodialysis versus short daily haemodialysis: a systematic review. Nephrol Dial Transplant 2008; 10: 1–13.
Ipema KJR, Health B, van der Schans CP, et al. A difference between day and night: protein intake improves after the transition from conventional to frequent nocturnal home hemodialysis. J Ren Nutr. 2012;22:365–72.
Kaysen GA, Greene T, Larive B, Mehta RL, et al. The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial. Kidney Int. 2012;82:90–9.
Hutson B, Stuart N. Nutrition management of the adult hemodialysis patient. In: A clinical guide to nutrition care in kidney disease. 2nd ed. Chicago: American Dietetic Association; 2013.
Rocco MV, Paranandi L, Burrowes JD, Cockram DB, et al. Nutritional status in the HEMO study cohort at baseline. Am J Kidney Dis. 2002;39:245–56.
Burrowes JD, Larive B, Cockram DB, Dwyer J, et al. Effects of dietary intake, appetite and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross sectional results from the HEMO study. J Ren Nutr. 2003;13:191–8.
Laville M, Fouque D. Nutritional aspects of hemodialysis. Kidney Int. 2000;58:133–9.
Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, et al. Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int. 1981;19:564–7.
Bodnar DM, Busch S, Fuchs J, Piedmonte M, et al. Estimating glucose absorption in peritoneal equilibration tests. Adv Perit Dial. 1993;9:114–8.
Burkart J. Metabolic consequence of peritoneal dialysis. Semin Dial. 2004;17:498–504.
Chhabra D, Nash K. Icodextrin: an alternative peritoneal dialysis fluid. Expert Opin Drug Metab Toxicol. 2008;4:1455–64.
McCann L. Nutrition management of the adult peritoneal dialysis patient. In: A clinical guide to nutrition care in kidney disease. 2nd ed. Chicago: American Dietetic Association; 2013.
Hamburger RJ, Iknaus MA. Icodextrin fulfills unmet clinical need of PD patients: improved ultrafiltration. Dial Transplant. 2003;32:675–84.
Teitelbaum I, Burkart J. Peritoneal dialysis. Am J Kidney Dis. 2003;42:1082–96.
McPhatter LL. Nocturnal home hemodialysis. In: A clinical guide to nutrition care in kidney disease. 2nd ed. Chicago: American Dietetic Association; 2013.
Cianciaruso B, Brunori G, Traverso G, Paanarello G, et al. Nutritional status in the elderly patient with uraemia. Nephrol Dial Transplant. 1995;10:65–8.
Chauveau P, Combe C, Laville M, Fouque D, et al. Factors influencing survival in hemodialysis patients aged older than 75 years: 2.5 year outcome study. Am J Kidney Dis. 2001;37:997–1003.
Wolfson M. Nutrition in elderly dialysis patients. Semin Dial. 2002;15:113–5.
Burrowes JD, Dalton S, Backstrand J, Levin NW. Patients receiving maintenance hemodialysis with low vs high levels of nutritional risk have decreased morbidity. J Am Diet Assoc. 2005;105:563–71.
Heimburger O, Stenvinkel P, Lindholm B. Nutritional effects and nutritional management of chronic peritoneal dialysis. In: Kopple JD, Massry SG, editors. Kopple and Massry’s nutritional management of renal disease. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 477–510.
Lindholm B, Bergstrom J. Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol. 1988;30:S59–63.
Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1982;21:849–61.
Kopple JD, Blumenkrantz MJ. Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1983;16:S295–302.
Galland R, Traeger J. Short daily hemodialysis and nutritional status in patients with chronic renal failure. Semin Dial. 2004;2:104–8.
Ayus JC, Achinger SG, Mizani MR, Chertow GM, et al. Phosphorus balance and mineral metabolism with 3 h daily dialysis. Kidney Int. 2007;71:336–42.
Hagen JM, Boyle CA, Hamburger VE, Sandroni CC, et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis. 1998;32:761–9.
Lindholm B, Bergstrom J. Nutritional aspects on peritoneal dialysis. Kidney Int. 1992;42:S165–71.
Tjiong HL, van den Berg JW, Wattimena JL, Rietveld T, et al. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol. 2005;16:1486–93.
Ahmad S. Dietary sodium restriction for hypertension in dialysis patients. Semin Dial. 2004;17:284–7.
Wilson J, Shah T, Nissenson AR. Role of sodium and volume in the pathogenesis of hypertension in hemodialysis. Semin Dial. 2004;17:260–4.
Goldstein-Fuchs J. Nutrition intervention for chronic renal diseases. In: Mitch WE, Klahr S, editors. Handbook of nutrition and the kidney. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 267–301.
McCann L. Pocket guide to nutrition assessment of the patient with chronic kidney disease. 4th ed. New York: National Kidney Foundation; 2009.
Testa A, Plou A. Clinical determinants of interdialytic weight gain. J Ren Nutr. 2001;11:155–60.
Moncrief JW. Continuous ambulatory peritoneal dialysis. Contrib Nephrol. 1979;17:139–45.
Nolph KD, Sorkin MI, Moore H. Autoregulation of sodium and potassium removal during continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs. 1980;26:334–8.
Lameire N, Van Biesen W. Hypervolemia in peritoneal dialysis patients. J Nephrol. 2004;17:58–66.
Wang X, Axelesson J, Lindholm B, Wang T. Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients. Blood Purif. 2005;23:373–8.
Krediet RT, van Westrhenen R, Zweers MM, Struijk DG. Clinical advantages of new peritoneal dialysis solutions. Nephrol Dial Transplant. 2002;17:16–8.
Davies SJ, Phillips L, Naish PF, Russel GI. Peritoneal glucose exposure and changes in membrane transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001;12:1046–51.
Beto J, Bansai VK. Hyperkalemia: evaluating dietary and non-dietary etiology. J Ren Nutr. 1992;2:28–9.
Musso CG. Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5). Int Urol Nephrol. 2004;36:469–72.
Constantino J, Roberts C. Life-threatening hyperkalemia from chewing tobacco in a hemodialysis patient. J Ren Nutr. 1997;7:106–8.
Ifudu O, Reydel K, Vlacich V, Delosreyes G, et al. Dietary potassium is not the sole determinant of serum potassium concentration in hemodialysis patients. Dial Transplant. 2004;33:684–8.
Rostand SG. Profound hypokalemia in continuous ambulatory peritoneal dialysis. Arch Intern Med. 1983;143:377–8.
Pierratos A, Ouwendyk M, Francoeur R, Vas S, et al. Nocturnal hemodialysis: three year experience. J Am Soc Nephrol 1998;9:859–868.
Argoudelis A, McCarty C, Re R, et al. Phosphorus and potassium removal with short daily hemodialysis. In: Poster presentation. Annual dialysis conference 2009.
Kohn OF, Coe FL, Ing TS. Solute kinetics with short-daily home hemodialysis using slow dialysate rate flow. Hemodial Int. 2010;14:39–46.
Goodman WG. Calcium, phosphorus and vitamin D. In: Handbook of nutrition & the kidney. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 47–69.
Qunibi WY. Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD). Kidney Int. 2004;66:S8–12.
Coladonato JA. Control of hyperphosphatemia among patients with ESRD. J Am Soc Nephrol. 2005;16:S107–14.
Rodrigues-Benot A, Martin-Malo A, Alvarez-Lara A, Rodriguez M, et al. Mild hyperphosphatemia and mortality in hemodialysis patients. Am J Kidney Dis. 2005;46:68–77.
Block GA, Klassen PS, Lazarus M, Ofsthun N, et al. Mineral metabolism, mortality and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–18.
McCann L. Total calcium load in dialysis patients: an issue of concern for dietitians. Dial Transplant. 2004;33:282–9.
National Kidney Foundation. Clinical practice guidelines: bone metabolism and disease in chronic renal failure. Am J Kidney Dis. 2003;42:S12–143.
Murphy-Gutekunst L. Hidden phosphorus in popular beverages: Part I. J Ren Nutr. 2005;15:e1–6.
Lockridge RS, Spencer M, Craft V, Pipkin M, et al. Nightly home hemodialysis: five and one-half years of experience in Lynchburg, Virginia. Hemodial Int. 2004;8:61–9.
Schulman G. Nutrition in daily dialysis. Am J Kidney Dis. 2003;41:S112–5.
Goldstein-Fuchs J. Dyslipidemias in chronic kidney disease. In: A clinical guide to nutrition care in kidney disease. 2nd ed. Chicago: American Dietetic Association; 2013.
National Kidney Foundation. KDOQI clinical practice guidelines for managing dyslipidemia in chronic kidney disease patients. Am J Kidney Dis. 2003;41:S1–91.
Saltissi D, Morgan C, Knight B, Chang W, et al. Effect of lipid-lowering dietary recommendations on the nutritional intake and lipid profiles of chronic peritoneal dialysis patients and hemodialysis patients. Am J Kidney Dis. 2001;37:1209–15.
Fried L, Hutchison A, Stegmayr B, Prichard S, et al. Recommendations for the treatment of disorders in patients on peritoneal dialysis. Perit Dial Int. 1999;19:7–21.
Masud T. Trace elements and vitamins in renal disease. In: Handbook of nutrition & the kidney. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 196–217.
Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults. JAMA. 2002;287:3127–9.
Coveney N, Polkinghorne KR, Linehan L, et al. Water-soluble vitamin levels in extended hours hemodialysis. Hemodial Int. 2010;15:30–8.
Kannampuzha J, Donnelly SM, McFarlane PA, et al. Glutathione and riboflavin status in supplemented patients undergoing home nocturnal hemodialysis versus standard hemodialysis. J Ren Nutr. 2010;20:199–208.
Makoff R, Gonick H. Renal failure and the concomitant derangement of micronutrient metabolism. Nutr Clin Pract. 1999;14:238–46.
Kasama R, Koch T, Canals-Navas C, Pitone JM. Vitamin b6 and hemodialysis: the impact of high-flux/high efficiency dialysis and review of the literature. Am J Kidney Dis. 1996;27:680–6.
Rocco MV, Makoff R. Appropriate vitamin therapy for dialysis patients. Semin Dial. 1997;10:272–7.
Hung SC, Hung SH, Tarng DC, Yang WC, et al. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001;38:941–7.
Handleman GJ, Levin NW. Guidelines for vitamin supplements in chronic kidney disease patients: what is the evidence? J Ren Nutr. 2011;21:117–9.
Jung U, Helbich-Endermann M, Bitsch R, Schenider BR, et al. Are patients with chronic renal failure (CRF) deficient in biotin and is regular biotin supplementation required? Z Ernahrungswiss. 1998;37:363–7.
Jones WO, Nidus BD. Biotin and hiccups in chronic dialysis patients. J Ren Nutr. 1991;1:80–3.
Wiggins KL. Renal care: resources and practical applications. Chicago: American Dietetic Association; 2004. p. 39–60.
Shemin D, Bostom AG, Selhub J. Treatment of hyperhomocysteinemia in end-stage renal disease. Am J Kidney Dis. 2001;38:S91–4.
Obeid R, Kuhlmann MK, Kohler H, Herrmann W. Response of homocysteine cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients. Clin Chem. 2005;51:196–201.
Clement L. Homocysteine: the newest uremic toxin? Renal Nutr Forum. 2003;23:1–4.
Schaefer RM, Tschner M, Kosch M. Folate metabolism in renal failure. Nephrol Dial Transplant. 2002;17:24–7.
Handelman GJ. New insight on vitamin C in patients with chronic kidney disease. J Ren Nutr. 2011;21:110–2.
Khajehdehi P, Mojerlou M, Behzadi S, Rais-Jalali GA. A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. Nephrol Dial Transplant. 2001;16:1448–51.
Muth I. Implications of hypervitaminosis A in chronic renal failure. J Ren Nutr. 1991;1:2–8.
Holden RM, Ki V, Morton AR, Clase C. Fat-soluble vitamins in advanced CKD/ESRD: a review. Semin Dial. 2012;25:334–43.
Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, et al. Meta-analysis: high dose vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37–46.
Kohlmeier M, Saupe J, Shearer MJ, et al. Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int. 1997;51:1218–21.
Rucker D, Thadhani R, Tonelli M. Trace elements status in hemodialysis patients. Semin Dial. 2010;23:389–95.
Erten Y, Kayata M, Sezer S, Ozdemir FN. Zinc deficiency: prevalence and causes in hemodialysis patients and effect on cellular immune response. Transplant Proc. 1998;30:850–1.
Matson A, Wright M, Oliver A, Woodrow G, et al. Zinc supplementation at conventional doses does not improve the disturbance of taste perception in hemodialysis patients. J Ren Nutr. 2003;13:224–8.
van der Eijk I, Allman Farinelli MA. Taste testing in renal patients. J Ren Nutr. 1997;7:3–9.
Smith AM, Temple K. Selenium metabolism and renal disease. J Ren Nutr. 1997;7:69–72.
Ng AHM, Hercz G, Kandel R, Grynpas MD. Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy. Bone. 2003;34:216–24.
Skikine BS, Ahluwalia B, Fergusson B, Chonko A, et al. Effects of erythropoietin therapy on iron absorption in chronic renal failure. J Lab Clin Med. 2000;135:452–8.
Cook JD, Dassenko SA, Whittaker P. Calcium supplementation: effect on iron absorption. Am J Clin Nutr. 1991;53:106–11.
Hallberg I, Hulten L, Gramatkovski E. Iron absorption from the whole diet in men: how effective is the regulation of iron absorption? Am J Clin Nutr. 1997;66:347–56.
Acknowledgment
Although Dr. Graeme Mendel did not contribute to the chapter in this edition, his previous contribution is invaluable and has been left largely intact.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wiesen, K. (2014). Dialysis. In: Byham-Gray, L., Burrowes, J., Chertow, G. (eds) Nutrition in Kidney Disease. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-685-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-62703-685-6_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-684-9
Online ISBN: 978-1-62703-685-6
eBook Packages: MedicineMedicine (R0)